Navigation Links
Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
Date:7/22/2013

AUSTIN, Texas, July 22, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it has passed a major milestone by shipping its 10,000th multiplexing instrument. This milestone was achieved by shipping a MAGPIX® instrument to Dr. Kimberle Chapin at the Rhode Island Hospital in Providence, R.I., the largest hospital and only Level I trauma center in the state. This MAGPIX instrument will be used initially for assay validation of Luminex's xTAG® Gastrointestinal Pathogen Panel. 

(Photo: http://photos.prnewswire.com/prnh/20130722/DA51004)

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

"Shipping our 10,000th instrument is an achievement that every Luminex employee is very proud of," said Patrick J. Balthrop, president and chief executive officer of Luminex. "The substantial installed base of Luminex instruments is a testament to the flexibility of our xMAP® Technology and to the open architecture upon which our customers and partners can build their assays. It is gratifying to know that our 10,000th instrument will be used by Dr. Kimberle Chapin and her excellent team. The ability to streamline gastroenteritis testing and deliver comprehensive, timely results is important to laboratories across the country."

Since shipping its first Luminex® 100™ multiplexing instrument, Luminex has continued to drive innovation in multiplexing products and services to the global healthcare and life science research communities. Luminex is known for developing many first-to-market molecular assays, such as the first multiplex cystic fibrosis assay, the first respiratory viral panel and most recently the first gastrointestinal pathogen panel. Luminex's portfolio of multiplexing instruments and assays addresses a broad range of laboratory and budgetary needs for life science research, clinical diagnostics, and biosurveillance.  The instrument line includes the 100-plex Luminex 100/200, the economical 50-plex MAGPIX and the high-throughput, 500-plex FLEXMAP 3D® systems.

Rhode Island Hospital is the principal teaching hospital of The Warren Alpert Medical School of Brown University.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.

Contacts:

Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director Investor Relations
mscalo@luminexcorp.com

Luminex Media Contact:
Mimi Torrington, 512.219.8020
Director of Marketing Communications
mtorrington@luminexcorp.com


'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
2. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
3. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
4. Luminex Corporation To Present At Upcoming Investment Conferences
5. Luminex Corporation Reports First Quarter 2013 Results
6. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
7. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
8. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
9. Luminex Corporation Reports Third Quarter 2012 Results
10. Luminex Corporation To Present At Upcoming Investment Conferences In September
11. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):